TCR2 Therapeutics recently announced that it has signed a long-term, full-binding lease with Alexandra Real Estate Equities for an existing 85,000 square foot cell therapy manufacturing...
Although the treatment prescribed to a patient by a doctor should be best tailored and personalized to the individual, drug affordability and access continues to be a challenge for patients in the...
GE Research and a multi-disciplinary team are receiving up to $41 million over the next five years to boost nucleic acid-based vaccine manufacturing and distribution.
The Defense Advanced...
The Biden Administration recently announced a historic collaboration between Johnson & Johnson and Merck to expand production of Johnson & Johnson’s COVID-19 vaccine,...
AstraZeneca recently announced that the first doses of its COVID-19 vaccine through the COVAX initiative have begun arriving in low and middle-income countries globally.
The first shipments were...
Moderna recently announced that it is making new capital investments to increase global manufacturing capacity of its COVID-19 vaccine, mRNA-1273.
The company will make investments to increase...
Eli Lilly and Company and Rigel Pharmaceuticals recently announced an agreement and strategic collaboration to codevelop and commercialize inhibitors for immunological and neurodegenerative...
Pfizer and BioNTech recently announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate their COVID-19 vaccine in healthy pregnant women.
The randomized,...
FDA has issued an emergency use authorization for a third COVID-19 vaccine to Johnson & Johnson, which will be distributed in the US for use in individuals 18 years of age and older.
The...
GSK and Vir Biotechnology recently signed an agreement to expand their existing collaboration to include the research and development of new novel therapies for influenza and other respiratory...
FDA recently approved G1 Therapeutics’ Cosela a therapy intended to reduce the frequency of chemotherapy-induced bone marrow suppression in adults for extensive-stage small-cell lung...
HHS and the Department of Defense (DoD) recently purchased an additional 100 million doses of COVID-19 vaccines from both Pfizer and Moderna to boost vaccine supply in the US.
The recent order brings...
In January 2020, prescription drug prices increased for 832 medications by an average of 4.6 percent, the largest increase that has occurred in years, according to a GoodRx analysis.
Of the...
The World Health Organization (WHO) recently granted AstraZeneca’s COVID-19 vaccine emergency use listing (EUL) for active immunization to prevent coronavirus in individuals 18 years of age and...
AstraZeneca and IDT Biologika recently partnered to boost manufacturing and supply capacity for COVID-19 Vaccine AstraZeneca in the second quarter of 2021.
The companies will also launch a joint...
Eli Lilly and Company recently partnered with local health systems to enhance access to crucial COVID-19 antibody therapies.
The partnership will work to launch dedicated infusion center...
CVS Health recently announced that it is expanding access to COVID-19 vaccines to eligible populations at a limited number of CVS Pharmacy locations across 11 states.
In total, there will be...
GSK and CureVac recently announced a $180.5 million collaboration to jointly develop next-generation mRNA COVID-19 vaccines.
The companies will contribute resources and expertise to research, develop,...
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently filed a complaint stating that the 340B Drug Pricing Program administrative dispute resolution (ADR) rule is “arbitrary...
Eight top pharmaceutical companies are moving to systematically enhance their drug development pipeline, with plans to boost access to products in low-and middle-income countries, according to the 2021...
